EA
PFE icon

Eclectic Associates’s Pfizer PFE Stock Holding History

Eclectic Associates’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,844
Closed -$248K – 165
2026
Q1 		$248K Sell
8,844
-565
-6% -$15K 0.03% 138
2025
Q4 		$234K Sell
9,409
-2,866
-23% -$72.3K 0.04% 128
2025
Q3 		$313K Sell
12,275
-1,128
-8% -$27.8K 0.06% 101
2025
Q2 		$325K Sell
13,403
-409
-3% -$9.54K 0.07% 100
2025
Q1 		$350K Buy
13,812
+1,838
+15% +$48.1K 0.09% 93
2024
Q4 		$318K Sell
11,974
-929
-7% -$25.2K 0.09% 99
2024
Q3 		$373K Sell
12,903
-1,974
-13% -$57.6K 0.15% 76
2024
Q2 		$416K Sell
14,877
-919
-6% -$25.3K 0.19% 61
2024
Q1 		$438K Sell
15,796
-1,006
-6% -$27.9K 0.2% 60
2023
Q4 		$484K Sell
16,802
-8,520
-34% -$258K 0.23% 52
2023
Q3 		$840K Buy
25,322
+797
+3% +$28.2K 0.43% 39
2023
Q2 		$900K Sell
24,525
-700
-3% -$27.2K 0.44% 38
2023
Q1 		$1.03M Buy
25,225
+651
+3% +$28.1K 0.53% 35
2022
Q4 		$1.26M Sell
24,574
-292
-1% -$14K 0.61% 36
2022
Q3 		$1.09M Sell
24,866
-2,246
-8% -$109K 0.71% 28
2022
Q2 		$1.42M Buy
27,112
+233
+0.9% +$11.9K 0.95% 23
2022
Q1 		$1.39M Buy
26,879
+322
+1% +$16.7K 0.89% 27
2021
Q4 		$1.57M Buy
26,557
+876
+3% +$43.4K 1% 21
2021
Q3 		$1.1M Buy
25,681
+865
+3% +$38.3K 0.81% 28
2021
Q2 		$972K Buy
24,816
+464
+2% +$18K 0.73% 31
2021
Q1 		$882K Buy
24,352
+638
+3% +$22.7K 0.73% 32
2020
Q4 		$873K Buy
+23,714
New +$870K 0.83% 31

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Eclectic Associates's PFE Position: Q2 2026 in Review

Eclectic Associates sold out of Pfizer (PFE) in Q2 2026, closing a stake of 8,844 shares — an estimated $248K sold.

Eclectic Associates first reported a position in PFE in Q4 2020 and held it in 22 quarters. The position peaked at $1.57M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Eclectic Associates reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Eclectic Associates sold 8,844 Pfizer shares in Q2 2026, an estimated $248K.
  • Eclectic Associates first reported a position in Pfizer in Q4 2020 and held it in 22 quarters.
  • Eclectic Associates's Pfizer position peaked at $1.57M in Q4 2021.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Eclectic Associates's 13F filing for Q2 2026, filed 7 Jul 2026.